Humana Inc (NYSE:HUM) saw a significant decrease in short interest in the month of September. As of September 15th, there was short interest totalling 1,410,000 shares, a decrease of 10.2% from the August 31st total of 1,570,000 shares. Based on an average daily volume of 665,500 shares, the days-to-cover ratio is currently 2.1 days. Approximately 1.1% of the shares of the company are sold short.
Shares of HUM traded down $7.05 during mid-day trading on Friday, reaching $408.31. The company had a trading volume of 521,457 shares, compared to its average volume of 1,090,193. The company’s 50 day simple moving average is $407.32 and its 200 day simple moving average is $378.37. Humana has a 1-year low of $208.25 and a 1-year high of $431.12. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.69 and a current ratio of 1.69. The company has a market capitalization of $54.02 billion, a price-to-earnings ratio of 15.53, a P/E/G ratio of 1.72 and a beta of 0.89.
Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, August 5th. The insurance provider reported $12.56 earnings per share for the quarter, beating analysts’ consensus estimates of $10.34 by $2.22. Humana had a net margin of 4.96% and a return on equity of 26.70%. The company had revenue of $19.08 billion for the quarter, compared to the consensus estimate of $18.66 billion. During the same period last year, the company posted $6.05 EPS. The firm’s quarterly revenue was up 17.5% compared to the same quarter last year. As a group, equities analysts forecast that Humana will post 19.02 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be paid a $0.625 dividend. The ex-dividend date of this dividend is Tuesday, September 29th. This represents a $2.50 dividend on an annualized basis and a dividend yield of 0.61%. Humana’s payout ratio is currently 13.99%.
Several equities analysts have recently weighed in on the stock. ValuEngine raised shares of Humana from a “sell” rating to a “hold” rating in a research report on Wednesday, September 2nd. Oppenheimer increased their price objective on shares of Humana from $425.00 to $440.00 and gave the company an “outperform” rating in a research report on Thursday, August 6th. Credit Suisse Group reissued a “buy” rating on shares of Humana in a research report on Thursday, August 6th. Goldman Sachs Group started coverage on shares of Humana in a research report on Friday, June 5th. They set a “buy” rating and a $510.00 price target on the stock. Finally, Mizuho raised their price target on shares of Humana from $420.00 to $462.00 and gave the stock a “buy” rating in a research report on Friday, August 7th. Eight investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $435.73.
Several institutional investors and hedge funds have recently bought and sold shares of the company. BlackRock Inc. boosted its stake in shares of Humana by 5.8% in the 2nd quarter. BlackRock Inc. now owns 11,438,186 shares of the insurance provider’s stock valued at $4,435,158,000 after purchasing an additional 627,841 shares in the last quarter. FMR LLC boosted its position in Humana by 28.6% during the 2nd quarter. FMR LLC now owns 7,882,151 shares of the insurance provider’s stock worth $3,056,304,000 after buying an additional 1,755,293 shares during the period. State Street Corp boosted its position in Humana by 0.7% during the 1st quarter. State Street Corp now owns 5,819,500 shares of the insurance provider’s stock worth $1,830,998,000 after buying an additional 39,441 shares during the period. Lone Pine Capital LLC boosted its position in Humana by 46.9% during the 1st quarter. Lone Pine Capital LLC now owns 2,164,071 shares of the insurance provider’s stock worth $679,562,000 after buying an additional 691,296 shares during the period. Finally, Janus Henderson Group PLC boosted its position in Humana by 35.4% during the 1st quarter. Janus Henderson Group PLC now owns 2,091,276 shares of the insurance provider’s stock worth $656,698,000 after buying an additional 546,774 shares during the period. Institutional investors own 92.43% of the company’s stock.
Humana Company Profile
Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.
Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.